Overview

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The main objective of this clinical trial is to investigate hepatic fat as the primary endpoint along with body fat, and weight changes after initiation of a basal insulin therapy together with data acquisition that is today's standard in studies investigating obesity and eating patterns with insulin detemir and insulin glargine.

Phase:

Phase 3

Details

Lead Sponsor:

University Hospital Tuebingen

Collaborators:

CenTrial GmbH
Medical University of Vienna
University of Bern

Treatments:

Insulin
Insulin Detemir
Insulin Glargine
Insulin, Globin Zinc